Ignite Creation Date:
2024-05-05 @ 11:13 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01280916
Status:
COMPLETED
Last Update Posted:
2018-11-19
First Post:
2011-01-12
Brief Title:
Mindful Awareness in Body-Oriented Therapy for Womens Substance Abuse Treatment
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Mindful Awareness in Body-Oriented Therapy for Womens Substance Abuse Treatment
Status:
COMPLETED
Status Verified Date:
2018-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this exploratory and developmental study is to evaluate a mind-body intervention for relapse prevention for women in addiction treatment The proposed intervention Mindful Awareness in Body-Oriented Therapy MABT is a novel mind-body intervention designed to enhance embodiment and to facilitate mindfulness through the combination of massage body awareness exercises and the acquisition of mindfulness skills The treatment goals of MABT include reduction of avoidant coping responses increase of emotional-regulation and decrease of trauma symptoms through access to and acceptance vs avoidance of sensory and emotional experience These are thought to be important for relapse prevention given the positive association between stress negative affect and relapse and risk of relapse associated with PTSD symptoms Mind-body interventions in relapse prevention are of increased clinical and scientific interest particularly for the potential to overcome automatic response patterns that are associated with lapse and relapse in substance use treatment This proposal falls within the current NIDA research portfolio focus on the development of interventions that will help people better cope with stress negative affect and trauma
Specific Aims
Aim 1 To examine feasibility of recruitment to and retention in MABT as an adjunct to substance abuse treatment Specifically to describe a study enrollment and barriers to recruitment b sample characteristics c response to randomization d session attendance and e loss to follow-up
Aim 2 To describe MABT acceptability to study participants and substance abuse treatment staff
Aim 3 To compare the effect of body-oriented therapy plus treatment-as-usual vs treatment-as-usual only on reported days abstinent for overall substance use and primary drug use among women receiving substance abuse treatment in order to estimate the effect size Secondary analyses will examine for intervention effects on related outcomes including days abstinence on biochemical screens for substance use body connection indicators avoidant coping stress reactivity co-morbid psychological distress and physical well-being
Specific Aims
Aim 1 To examine feasibility of recruitment to and retention in MABT as an adjunct to substance abuse treatment Specifically to describe a study enrollment and barriers to recruitment b sample characteristics c response to randomization d session attendance and e loss to follow-up
Aim 2 To describe MABT acceptability to study participants and substance abuse treatment staff
Aim 3 To compare the effect of body-oriented therapy plus treatment-as-usual vs treatment-as-usual only on reported days abstinent for overall substance use and primary drug use among women receiving substance abuse treatment in order to estimate the effect size Secondary analyses will examine for intervention effects on related outcomes including days abstinence on biochemical screens for substance use body connection indicators avoidant coping stress reactivity co-morbid psychological distress and physical well-being
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R21DA024771 | NIH | None | httpsreporternihgovquickSearchR21DA024771 |